Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

Journal of Virology

Volumn 76, Issue 24, 2002, Pages 13097-13100

  Beasley, David W C ^a   Barrett, Alan D T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STRAIN DIFFERENCE; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL MEMBRANE; EPITOPE MAPPING; MICE; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS; VIRULENCE; WEST NILE VIRUS;

EID: 0036891872     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.24.13097-13100.2002     Document Type: Article

References (17)

1. Beasley, D. W. C., L. Li, M. T. Suderman, and A. D. T. Barrett. 2001. West Nile virus strains differ in mouse neurovirulence and binding to mouse or human brain membrane receptor preparations. Ann. N. Y. Acad. Sci. 951:332-335.
2. Beasley, D. W. C., L. Li, M. T. Suderman, and A. D. T. Barrett. 2002. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296:17-23.
3. Bhardwaj, S., M. Holbrook, R. E. Shope, A. D. T. Barrett, and S. J. Watowich. 2001. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J. Virol. 75:4002-4007.
4. Cecilia, D., and E. A. Gould. 1991. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181:70-77.
5. Chambers, T. J., M. Halevy, A. Nestorowicz, C. M. Rice, and S. Lustig. 1998. West Nile virus envelope proteins: Nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J. Gen. Virol. 79:2375-2380.
6. Crill, W. D., and J. T. Roehrig. 2001. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75:7769-7773.
7. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-Pdb-Viewer: An environment for comparative protein modeling. Electrophoresis 18:2714-2723.
8. Holbrook, M. R., H. Ni, R. E. Shope, and A. D. T. Barrett. 2001. Amino acid substitution(s) in the stem-anchor region of Langat virus envelope protein attenuates mouse neurovirulence. Virology 286:54-61.
9. Jia, X.-Y., T. Briese, I. Jordan, A. Rambaut, H. C. Chi, J. S. MacKenzie, R. A. Hall, J. Scherret, and W. I. Lipkin. 1999. Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet 354:1971-1972.
10. Lanciotti, R. S., J. T. Roehrig, V. Deubel, J. Smith, M. Parker, K. Steele, B. Crise, K. E. Volpe, M. B. Crabtree, J. H. Scherret, R. A. Hall, J. S. Mac-Kenzie, C. B. Cropp, B. Panigrahy, E. Ostlund, B. Schmitt, M. Malkinson, C. Banet, J. Weissman, N. Komar, H. M. Savage, W. Stone, T. McNamara, and D. J. Gubler. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333-2337.
11. Lee, E., and M. Lobigs, 2000. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 74:8867-8875.
12. Mandl, C. W., S. L. Allison, H. Holzmann, T. Meixner, and F. X. Heinz. 2000. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J. Virol. 74:9601-9609.
13. Rey, F. A., F. X. Heinz, C. Mandl, C. Kunz, and S. C. Harrison. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291-298.
14. Ryman, K. D., T. N. Ledger, G. A. Campbell, S. J. Watowich, and A. D. T. Barrett. 1998. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology 244:59-65.
15. Serafin, I. L., and J. G. Aaskov. 2001. Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies. Arch. Virol. 146:2469-2479.
16. Solomon, T., and D. W. Vaughn. 2002. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr. Top. Microbiol. Immunol. 267:171-194.
17. Thullier, P., C. Demangel, H. Bedouelle, F. Megret, A. Jouan, V. Deubel, J.-C. Mazie and P. Lafaye. 2001. Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: Insight into the neutralization mechanism. J. Gen. Virol. 82:1885-1892.